Investigations on the involvement of the lectin pathway of complement activation in anaphylaxis

International Archives of Allergy and Immunology

Volumn 141, Issue 1, 2006, Pages 11-23

  Windbichler, Michaela ^a   Echtenacher, Bernd ^a   Takahashi, Kazue ^c   Ezekowitz, R Alan B ^c   Schwaeble, Wilhelm J ^b   Jensenius, Jens C ^d   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Anaphylactic shock; Chondroitin sulphate; Mannan binding lectin; Mast cells; Proteoglycans

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C5A RECEPTOR; LECTIN; LIGAND; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN A; MANNAN BINDING LECTIN C; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CELL ACTIVATION; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HYPOTHERMIA; IMMEDIATE TYPE HYPERSENSITIVITY; KNOCKOUT MOUSE; LIGAND BINDING; MAST CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SHOCK; SIGNAL TRANSDUCTION;

ANAPHYLAXIS; ANIMALS; COMPLEMENT ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; MANNOSE-BINDING LECTIN; MAST CELLS; MICE; MICE, INBRED DBA; MICE, MUTANT STRAINS; OVALBUMIN; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; RNA, MESSENGER;

EID: 33747314468     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094177     Document Type: Article

References (49)

1. Kemp SF, Lockey RF: Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002;110:341-348.
2. Lei HY, Lee SH, Leir SH: Antigen-induced anaphylactic death in mice. Int Arch Allergy Immunol 1996;109:407-412.
3. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P: Active anaphylaxis in IgE-deficient mice. Nature 1994;370:367-370.
4. Nagata S, Glovsky MM: Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation. J Allergy Clin Immunol 1987;80:24-32.
5. Del Balzo U, Polley MJ, Levi R: Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects. J Pharmacol Exp Ther 1988;246:911-916.
6. Van der Linden PW, Hack CE, Kerckhaert JA, Struyvenberg A, van der Zwan JC: Preliminary report: complement activation in wasp-sting anaphylaxis. Lancet 1990;336:904-906.
7. Regal JF, Fraser DG, Toth CA: Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig. J Pharmacol Exp Ther 1993;267:979-988.
8. Holmskov U, Thiel S, Jensenius JC: Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003;21:547-578.
9. Schwaeble WJ, Reid KB: Does properdin crosslink the cellular and the humoral immune response? Immunol Today 1999;20:17-21.
10. Stahl GL, Xu Y, Hao L, Miller M, Buras JA, Fung M, Zhao H: Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 2003;162:449-455.
11. Tannenbaum H, Ruddy S, Schur PH: Acute anaphylaxis associated with serum complement depletion. J Allergy Clin Immunol 1975;56:226-234.
12. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998;19:56-59.
13. Taylor PR, Nash JT, Theodoridis E, Bygrave AE, Walport MJ, Botto M: A Targeted disruption of the murine complement factor B gene resulting in loss of expression of three genes in close proximity, factor B, C2, and D17H6S45. J Biol Chem 1998;273:1699-1704.
14. Shi L, Takahashi K, Dundee J, Shahroor-Karni S, Thiel S, Jensenius JC, Gad F, Hamblin MR, Sastry KN, Ezekowitz RA: Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004;199:1379-1390.
15. Hopken UE, Lu B, Gerard NP, Gerard C: The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 1996;383:86-89.
16. Makabe-Kobayashi Y, Hori Y, Adachi T, Ishigaki-Suzuki S, Kikuchi Y, Kagaya Y, Shirato K, Nagy A, Ujike A, Takai T, Watanabe T, Ohtsu H: The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J Allergy Clin Immunol 2002;110:298-303.
17. Petersen SV, Thiel S, Jensen L, Steffensen R, Jensenius JC: An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods 2001;257:107-116.
18. Dodds AW: Small-scale preparation of complement components C3 and C4. Methods Enzymol 1993;223:46-61.
19. Liu H, Jensen L, Hansen S, Petersen SV, Takahashi K, Ezekowitz AB, Hansen FD, Jensenius JC, Thiel S: Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol 2001;53:489-497.
20. Thiel S, Moller-Kristensen M, Jensen L, Jensenius JC: Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002;205:446-454.
21. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB: Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995;1:237-243.
22. Roos A, Bouwman LH, Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha R: Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 2001;167:2861-2868.
23. Celik I, Stover C, Botto M, Thiel S, Tzima S, Kunkel D, Walport M, Lorenz W, Schwaeble W: Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Infect Immun 2001;69:7304-7309.
24. Van den Berg CW, Hofhuis FM, Rademaker PM, van Dijk H: Induction of active immunological hypo/non-responsiveness to C5 in adult C5-deficient DBA/2 mice. Immunology 1991;74:380-385.
25. Arnold JN, Radcliffe CM, Wormald MR, Royle L, Harvey DJ, Crispin M, Dwek RA, Sim RB, Rudd PM: The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol 2004;173:6831-6840.
26. Windbichler M, Echtenacher B, Hehlgans T, Jensenius JC, Schwaeble W, Mannel DN: Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis. Infect Immun 2004;72:5247-5252.
27. Collard CD, Montalto MC, Reenstra WR, Buras JA, Stahl GL: Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol 2001;159:1045-1054.
28. De Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, van Heurn LW, Buurman WA: The mannose-binding lectin pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004;165:1677-1688.
29. Uemura K, Saka M, Nakagawa T, Kawasaki N, Thiel S, Jensenius JC, Kawasaki T: L-MBP is expressed in epithelial cells of mouse small intestine. J Immunol 2002;169:6945-6950.
30. Ueki A, Sai T, Oka H, Tabata M, Hosokawa K, Mochizuki Y: Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro. Immunology 1987;61:11-14.
31. Strunk RC, Eidlen DM, Mason RJ: Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988;81:1419-1426.
32. Andoh A, Fujiyama Y, Bamba T, Hosoda S: Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 1993;151:4239-4247.
33. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM: Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003;170:1517-1523.
34. Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF: Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 1983;130:1891-1895.
35. Ward PA, Hill JH: C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 1970;104:535-543.
36. Johnson AR, Hugli TE, Muller-Eberhard HJ: Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 1975;28:1067.
37. Frank MM, Fries LF: The role of complement in inflammation and phagocytosis. Immunol Today 1991;12:322-326.
38. Okunuki H, Teshima R, Sakushima J, Akiyama H, Goda Y, Toyoda M, Sawada JI: Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast cell-deficient mice. Immunol Lett 2000;74:233-237.
39. Martin TR, Galli SJ, Katona IM, Drazen JM: Role of mast cells in anaphylaxis: evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J Clin Invest 1989;83:1375-1383.
40. Serafin WE, Austen KF: Mediators of immediate hypersensitivity reactions. N Engl J Med 1987;317:30-34.
41. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP: Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis: evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 1997;99:915-925.
42. Razin E, Stevens RL, Akiyama F, Schmid K, Austen KF: Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetyl-galactosamine-4,6- disulfate. J Biol Chem 1982;257:7229-7236.
43. Yurt RW, Leid RW Jr, Austen KF: Native heparin from rat peritoneal mast cells. J Biol Chem 1977;252:518-521.
44. Almeda S, Rosenberg RD, Bing DH: The binding properties of human complement component C1q: interaction with mucopolysaccharides. J Biol Chem 1983;258:785-791.
45. Sahu A, Pangburn MK: Identification of multiple sites of interaction between heparin and the complement system. Mol Immunol 1993;30:679-684.
46. Weiler JM, Edens RE, Linhardt RJ, Kapelanski DP: Heparin and modified heparin inhibit complement activation in vivo. J Immunol 1992;148:3210-3215.
47. Presanis JS, Hajela K, Ambrus G, Gal P, Sim RB: Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol Immunol 2004;40:921-929.
48. Monge JC, Recondo EF, Fernandez de Recondo ME: Heparin and concanavalin A interaction as a model for studying the mechanism of the anticoagulant activity. Thromb Res 1989;54:237-243.
49. Kazatchkine MD, Fearon DT, Metcalfe DD, Rosenberg RD, Austen KF: Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 1981;67:223-228.